This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
viewpoints
Welcome to Reed Smith's viewpoints — timely commentary from our lawyers on topics relevant to your business and wider industry. Browse to see the latest news and subscribe to receive updates on topics that matter to you, directly to your mailbox.
| less than a minute read

Leveraging AI to combat COVID-19

AI has been used to process patient data, biometric data, facial recognition data and geolocation data by various industries. But it has been criticized for potentially biased results and alleged invasion of user privacy.

During this global pandemic, AI industry leaders are applying their technology to new issues raised by the novel coronavirus (COVID-19). AI can aid in combating COVID-19 and improve our response to future pandemics. To reach AI’s full potential in a health crisis, access to vast quantities of patient data is necessary.

Governments, working with companies, could create exceptions to privacy regulations and agree globally to share patient data during crises. If constructed carefully with the potential for liability for data misuse, regulations can provide the data necessary to improve pandemic responses while protecting individuals’ privacy.

AI has the potential to revolutionize the global response to future pandemics. However, without access to mass, varied patient data, it cannot perform at its peak. Governments, working with companies, could create exceptions to privacy regulations and agree globally to share patient data during crises. If constructed carefully with the potential for liability for data misuse, regulations can provide the data necessary to improve pandemic responses while protecting individuals’ privacy.

Tags

artificial intelligence, pandemic, covid-19, ai, biometrics, technology, digital health, data